Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Leoclan CoTSE:7681 66 FCF Yield % is 26.24 as of Aug. 03, 2026, which is 564% above its 10-year median of 3.95. GuruFocus rates TSE:7681 with a GF Score™ of 66/100 and a GF Value™ of 円1,290.91 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 118 Medical Distribution companies, Leoclan Co ranks better than 91.53% on this metric.
FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.
Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Leoclan Co FCF Yield % Related Terms
Leoclan Co FCF Yield % Historical Data
* Premium members only.
The historical data trend for Leoclan Co's FCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Distribution subindustry, Leoclan Co's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Leoclan Co FCF Yield % vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Leoclan Co's FCF Yield % distribution charts can be found below:
* The bar in red indicates where Leoclan Co's FCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Leoclan Co (TSE:7681) has a FCF Yield % of 26.24 as of Aug. 03, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Leoclan Co and its competitors. This is 564% above median its historical median of 3.95. According to the industry distribution chart, Leoclan Co ranks #10 out of 118 companies in the Medical Distribution industry, placing it in the top 8.5%.
Is Leoclan Co's FCF Yield % too high?
Leoclan Co's current FCF Yield % of 26.24 is 564% above median its 10-year median of 3.95. The Medical Distribution industry median FCF Yield % is 1.82. Leoclan Co's value of 26.24 is 1341.8% above this industry median. Based on the distribution chart, Leoclan Co ranks #10 out of 118 companies in the Medical Distribution industry, which is in the top quartile — a strong position relative to peers. Overall, Leoclan Co has a GF Score™ of 66/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Leoclan Co's FCF Yield % compare to MCK and COR?
According to the Medical Distribution industry distribution chart, Leoclan Co ranks #10 out of 118 companies for FCF Yield %. This places Leoclan Co in the top 9% of its industry — outperforming the majority of peers. The industry median FCF Yield % is 1.82. Leoclan Co's value of 26.24 is 1341.8% above this benchmark. While the company's 10-year median is 3.95 vs. the industry median of 1.82, Leoclan Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Yield % for a Medical Distribution company?
The median FCF Yield % among Medical Distribution companies is 1.82, based on 118 companies in the industry. Companies in the top quartile (top 25%) have a FCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Leoclan Co's current FCF Yield % of 26.24 is 1341.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Yield % mean?
A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Leoclan Co and its competitors. For the Medical Distribution industry, the median FCF Yield % is 1.82 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Leoclan Co's current FCF Yield % is 26.24, which is 564% above median its own 10-year median of 3.95. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Leoclan Co stock overvalued right now?
Based on GuruFocus' analysis, Leoclan Co (TSE:7681) is currently considered Modestly Undervalued. The stock's GF Value™ is 円1,290.91, compared to a current price of 円955.00 — trading 26% below its estimated fair value. The current FCF Yield % is 26.24, which is 564% above median its 10-year median of 3.95 and 1341.8% above the Medical Distribution industry median of 1.82. Leoclan Co's overall GF Score™ is 66/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Yield % calculated?
FCF Yield % is calculated from a company's financial statements. For Leoclan Co (TSE:7681), the current FCF Yield % is 26.24 as of Aug. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Leoclan Co (TSE:7681) Overvalued in 2026?
Based on GuruFocus' analysis, Leoclan Co stock appears to be undervalued.
The current stock price of 円955.00 is trading 26% below its estimated GF Value™ of 円1,290.91.
GuruFocus considers Leoclan Co to be Modestly Undervalued.
Key valuation signals for TSE:7681:
FCF Yield %: 26.24 (564% above median its 10-year median of 3.95)
GF Value™: 円1,290.91 vs. price of 円955.00 (26% below fair value)
Industry Position: 1341.8% above the Medical Distribution median (#10 of 118)
No single metric tells the full story. See the TSE:7681 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:7681 has been successfully added to your 
